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The effect of intraduodenally administered cattle bile (CB) and Na-taurodeoxycholate 
(TDC) on basal pancreatic secretion and plasma levels of secretin, pancreatic poly- 
peptide (PP), and gastrin were investigated on two separate days in 10 fasting 
volunteers. Doses of 2-6 g CB and 20&600 mg TDC were given intraduodenally at 
65-min intervals. Volume, bicarbonate, lipase, trypsin, amylase, and bilirubin were 
measured in 10-min fractions of duodenal juice, and GI peptides determined by 
radioimmunoassay. CB and TDC enhanced significantly and dose-dependently 
volume, bicarbonate and enzyme secretion, and plasma secretin and PP levels. In 
contrast, plasma gastrin showed only a marginal increase. We conclude :hat the 
hydrokinetic effect of intraduodenal CB and TDC is at least partially mediated by 
secretin. Gastrin could be ruled out as a mediator of the ecbolic effect, whereas other 
GI peptides, primarily CCK, and/or neural mechanisms must be considered possible 
mediators. Both pathways may also play a role in the PP release observed. 
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Conflicting reports exist on the effect of intra- 
duodenal bile and bile salts on exocrine pancreatic 
secretion (1-8). We have previously shown that 
intraduodenal cattle bile (CB) enhanced secretin- 
stimulated hydrokinetic and ecbolic pancreatic 
secretion in man dose-dependently (9). In 
addition, Na-taurodeoxycholate (TDC) proved to 
be nearly as effective as total bile. 
The mediators of bile- and bile salt-induced 
effects on both hydrokinetic and ecbolic pan- 
creatic secretion are still poorly defined. Osnes et 
al. (10) were the first to show that intraduodenal 
infusion of bile in man elicited significant plasma 
secretin concentrations and pancreatic secretion. 
In other studies, however, plasma secretin was 
not significantly influenced by bile (11, 12). Fur- 
thermore, various bile salts were capable of 
increasing plasma secretin concentrations but 
only when applied in high doses (13). 
The aim of the present study was to investigate 
the effect of physiologic doses of a standardized 
CB preparation and TDC intraduodenally on 
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basal pancreatic secretion and on plasma levels 
of secretin, gastrin, and pancreatic polypeptide 
( W .  
MATERIALS AND METHODS 
Experimental procedure 
The study was carried out  on 10 fasting healthy 
volunteers (age, 25 & 0.8 years; weight, 69.1 +- 
3.3 kg). Under fluoroscopic control the tip of a 
double-lumen Dreiling tube was advanced to  the 
ligament of Treitz, enabling continuous and sep- 
arate aspiration of gastric and pancreatic juice. 
Details have been described earlier (9). 
On one day each person received standardized 
dried CB (kindly supplied by Kali-Chemie, FRG) 
intraduodenally, dissolved in 20 ml H 2 0 ,  in doses 
of 2 (twice), 4, and 6 g (310,639, and 937 mosmol/ 
I ;  pH 7.45, 7.18, and 7.04, respectively), and on 
another day the same persons received chro- 
matographically pure T D C  (Calbiochem- 
Behring, FRG) intraduodenally, again dissolved 
in 20ml HzO. in doses of 200 (twice), 400, and 
600 mg (19.0, 38.5, and 57.5 mmol/l; 33.0, 50.0, 
and 67.0 mosmol/l; p H  7.9, 8.1, and 8.1, respect- 
ively), at 65-mi11 intervals. Aspiration of duodenal 
,juice was interrupted for 5 min immediately after 
instillation t o  ensure sufficient contact of the stim- 
uli with the duodenal mucosa. Thereafter, col- 
lection in 10-min fractions of duodenal juice was 
continued. Besides the volume and pH,  the con- 
centrations o f  bicarbonate, lipase, trypsin, 
amylase, and bilirubin were measured. The deter- 
mination of bicarbonate and of pancreatic 
enzymes was performed in accordance with the 
recommendation of the Multi Centre Study of the 
European Pancreatic Club (14). Blood samples 
for radioimmunologic determination of secretin, 
PP, and gastrin were withdrawn in ice-chilled 10- 
ml syringes (containing 37.1 ymol K,-ethylene- 
diaminetetraacetic acid (EDTA) and 5000 KIU 
aprotinin) before, a t ,  and 5,  10, 15, 25, 45, and 
65 inin after intraduodenal stimulation. The 
samples were left on ice until centrifugation at 
4°C. and the plasma was immediately frozen in 
1.5-nil aliquots. 
'The first stimulus in each series-2g CB and 
200 mg TDC,  respectively-was given to 'wash 
out' preformed zymogens from the pancreatic 
ducts. The preparation of CB used in this study 
contained 10% TDC based on weight. Doses of 
TDC were therefore applied corresponding to 
their CB content. 
Radioimmunoassay procedures 
Secretin. Secretin was measured radioimmuno- 
logically in acidified plasma in accordance with 
Burhol & Waldum (15). The antiserum to pure 
porcine secretin was produced in rabbits by the 
method of Burhol & Waldum (16). The effective 
equilibrium constant (&) was 1.6 X 10" l/inol. 
and the index of heterogeneity (a) 1.0. The anti- 
serum showed no cross-reactivity against the pep- 
tides of the secretin-glucagon family and PP. 
Synthetic porcine secretin was labelled with 
iodine-125 by a modified chloramine-T technique 
(17) and subjected to gel chromatography. High 
specific radioactivity of approximately 42.4 MBq/ 
nmol, as calculated by the method of Morris e t  
al. (18), was obtained by purification on a cation 
exchange column. The immunoreactivity of 125- 
iodinated secretin was identical to that of 
unlabelled synthetic secretin as evaluated by 
Scatchard plots (19). 
Incubation was performed in triplicate poly- 
styrol tubes at  4°C. Two hundred microlitres 
'secretin-free' charcoaled pool plasma, synthetic 
porcine secretin standards in charcoaled pool 
plasma, and unknown plasma samples, respect- 
ively, were preincubated with 15 pl 1 M HC1 for 
1 h. Afterwards, 200 pl assay buffer (0.1 M 
sodium acetate buffer, p H  5.0, containing 
0.07 mmol/l bovine serum albumin (BSA). 
3.08 mmol/l NaN,, and 1000 KIU aprotinin/ml) 
and 100pl suspension of a secretin antiserum/ 
anti-rabbit gammaglobulin antiserum precipitate 
(dilution of secretin antiserum, 1 :15,000, and of 
goat anti-rabbit gammaglobulin antiserum, 1:40; 
9 pg rabbit gammaglobulin/l00 pl suspension 
caused maximal precipitation) were added. After 
72 h ,  100 pl of tracer solution (=3000 cpm) were 
added to each tube; after another 48 h of incu- 
bation bound and free label were separated by 
centrifugation at  4"C, the supernatant removed 
by suction, and the precipitate counted in an 
automatic gamma-counter. The standard curves 
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Fig. 1. Effect of 2, 2, 4, and 6 g CB intraduodenally (left) and of 200, 200, 400, and 600 mg TDC intraduodenally 
(right) on plasma secretin concentrations and on pancreatic volume and bicarbonate secretion (n  = 10). Asterisks 
indicate significant difference from ‘basal’ values (also in all subsequent figures). 
were calculated by a computerized ‘spline 1) added to human charcoaled plasma was 106%, 
function’ algorithm (RiaCalc LM, LKB-Phar- respectively. Mean plasma secretin concentration 
macia). of 22 fasting subjects was 3.5 * 0.3 pmol/l. The 
The detection limit of the assay was 1 pmol/l coefficient of variation for the within-assay pre- 
with 95% confidence limit. Recovery of known cision was 13.4% and 4.6% at 7.7pmol/l and 
amounts of porcine secretin (5.6 and 11.2pmol/ 29.6 pmol/l, respectively, and for the between- 
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assay precision 12.796, 6.796, and 9.9% at 3.9, 
11.6, and 28.1 pmol/l secretin, respectively. Fur- 
thermore, gel chromatography studies showed 
that human secretin stimulated by 4 mmol HCI 
intraduodenally, pure porcine secretin in human 
charcoaled plasma, and '"I-labelled porcine 
secretin in assay buffer were eluted at identical 
posit i o 11 s . 
Plusnia PP. Plasma PP concentrations were 
determined by radioimmunoassay (RIA) using an 
anti-porcine PIP antiserum (K 5418, cross-reac- 
tivity with human PP >95%) and 12s"I-labelled 
porcine PP (specific radioactivity, 54 MBq/nmol), 
supplied by the Novo Research Institute, Copen- 
hagen, Denmark. The antibody showed no cross- 
reactivity against neuropeptide Y, peptide YY, 
pcptides o f  the secretin-glucagon family, somato- 
statin-14, cholecystokinin-39 (CCK-39), gastrin- 
17. and insulin. Incubations were performed in a 
0.05 M sodium phosphate buffer, pH 7.4, con- 
taining 0.07 rnrnol/l BSA, 3.08 mmol/l NaN,, and 
~ 0 0 0  KlU aprotinin/ml for 96 h at  4°C. One  hun- 
drcd microlitres of plasma sample or of human 
PP standard (Sigma Chemie) dissolved in 'PP- 
free' charcoaled plasma, 200 kl suspension of an 
anti-porcine PP antiserum/anti-rabbit gamma- 
globulin antiserum precipitate (dilution of PP 
antiserum, 1 :Y00,000, and of goat anti-rabbit 
gammaglobulin antiserum, 1:YO; 4.2 pg rabbit 
gammaglobulin/100 fil suspension caused maxi- 
mal precipitation), and 100 ~1 of '2SI-labelled PP 
(-3000 cpm) were mixed together. Antibody- 
hound radioactivity was separated, and the stan- 
dard curves were calculated as described for 
secretin. The detection limit for human PP (95% 
confidence level) was 3.7 2 0.3 pmol/l; the intra- 
and inter-assay coefficients of variation for trip- 
licates were 11.1% at 12.9 pmol/l (n  = 8) and 
13.1% at 14.3 pmol/l ( n  = 17), respectively. Fast- 
ing EDTA plasma of 30 subjects contained 
15.5 rt_ 5.8 pmoI/I PP. 
Gustrin. Gastrin was measured in EDTA 
plasma by a commercially available radioimmu- 
noassay kit (CASK-PR, Isotopen Diagnostik 
CIS, Dreieich, FRG) with a detection limit of 
10  pg/ml, an intra-assay variation of 8.9% at 45.8 
pg/ml, and an interassay variation of 9.9% at 
53.9 pg/ml. On a molar basis the antibody shows 
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Fig. 2. Dose-response curves o f  intraduodenal CB (left) 
and of intraduodenal TDC (right) on integrated plasma 
secretin and on pancreatic volume and hicarhonate out- 
put (n = 10) (semilogarithmic plot). 
100% cross-reactivity with human gastrin-17, 
72% with human gastrin-34, and I o/c with chole- 
cystokinin-33. 
Statistical methods 
Changes in concentrations and outputs were 
evaluated by the Friedman two-way analysis of 
variance. The level of statistical significance was 
p < 0.05. In all figures values are presented as 
X f SEM. Integrated GI peptide values were cal- 
culated as the areas under the concentration 
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Fig. 3. Effect of 2, 2, 4, and 6 g CB intraduodenally (left) and of 200, 200, 400, and 600 mg TDC intraduodenally 
(right), respectively, on plasma concentrations of PP and gastrin and on pancreatic trypsin secretion (n  = 10). 
Trypsin is representative for all enzymes measured. 
RESULTS 
curves for 10min after the application of each 
intraduodenal stimulus. The Wilcoxon test for Four and 6 g CB intraduodenally caused a signifi- 
paired data was used to  examine corresponding cant increase of plasma secretin concentrations 
values after intraduodenal CB and TDC,  respect- and of pancreatic volume and bicarbonate 
ively, for significant difference. secretion rate within 10 min. Plasma secretin rose 
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significantly also after 2 g CB,  but there was only a 
non-significant effect on volume and bicarbonate 
secretion. TDC intraduodenally enhanced sig- 
nificantly plasma secretin concentrations and vol- 
ume and bicarbonate secretion rate within 10 min 
at all given doses (Fig. 1). Integrated plasma 
secretin secretion and volume and bicarbonate 
output also showed a significant and dose-depen- 
dent increase after all doses of CB and TDC,  
except for volume and bicarbonate output after 
Zg CB (Fig. 2 ) .  
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Fig. 4. Dose-response curves o f  intraduodenal CB (left) 
and of  intraduodenal TDC (right) on intcgrated plasma 
PP and gastrin and on pancreatic trypsin output ( 1 1  = 
10). Trypsin is rcpresentative of all enzymes measured 
(scmilogarittimic plot). 
Trypsin secretion rate-representative of all 
pancreatic enzymes measured-rose significantly 
after 4 and 6 g CB intraduodenally and also after 
all doses of T D C  intraduodenally (Fig. 3). Trypsin 
output showed a dose-dependent increase after 
2 and 4 g  CB and after 200 and 400mg TDC. 
However, there was no further augmentation 
after the highest dose of both stimuli (Fig. 4). 
Plasma PP concentrations were significantly 
raised by all doses of CB and TDC, especially 
after the highest doses (Fig. 3). Integrated plasma 
PP secretion rose significantly and dose-depen- 
dently after intraduodenal application of 4 and 
6 g CB and also after all doses of TDC (Fig. 4). 
In contrast, plasma gastrin concentrations rose 
but unessentially, and integrated plasma gastrin 
secretion did not change significantly a t  all given 
doses of CB and TDC (Figs. 3 and 4). 
When the stimulatory potencies of CB and 
T D C  were compared, a significant difference was 
only found for bicarbonate output after the 
respective highest dose. 
DISCUSSION 
The present study shows a dose-dependent hydro- 
kinetic and ecbolic effect of intraduodenal CB 
and T D C  on basal pancreatic secretion in mail. 
The results confirm our previous findings during 
a constant infusion of secretin (9). 
Instead of human bile a standardized CB prep- 
aration was used in our  studies to establish a dose- 
response relationship. The contents of total bile 
salts in human gallbladder bile and in our CB 
preparation are comparable (20). The proportion 
of chenodeoxycholate and its conjugates in CB, 
however, was lower in favour of cholate and its 
conjugates. 
In pure pancreatic juice obtained by endoscopic 
retrograde pancreatography Osnes et al. (21) 
observed an increase of volume, bicarbonate, and 
amylase secretion and of plasma secretin concen- 
tration after repeated intraduodenal instillation 
of 6 g  CB. Trypsin and lipase output, however, 
was enhanced significantly only after the first 
stimulus. Therefore, the influence of intraduo- 
denal CB on ecbolic secretion was ascribed to 
a 'washing out' effect by secretin. These contra- 
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dictory results may be attributed to the rapid 
follow-up study of the intraduodenal stimuli 
without reaspiration of bile. Therefore, peripap- 
illary cholinergic receptors might have been 
blocked (21,22). 
In accordance with other investigators (3,8, 
23), our previous studies show (2,9) that bile 
salts are the effective constituents of bile. Their 
stimulatory effect seems to be independent of 
their action as detergents (24). However, only 
some bile salts, such as TDC, act as specific intra- 
duodenal stimulants of pancreatic secretion (9). 
TDC represents approximately 8mol % of the 
total bile salts in human bile and approximately 
10 mol % of the bile salts in the CB preparation 
used. The amounts of TDC applied in our study 
are in the physiologic range and comparable with 
those contained in CB. The concentrations of 
TDC used (2G60mM) are above the critical 
micellar concentration and similar to those found 
in human gallbladder bile (20,25). Postprandial 
intraduodenal bile salt concentrations are lower 
(up to 20mM), but the TDC solutions applied 
have also been diluted intraduodenally by pan- 
creatic and duodenal juice. 
TDC is almost as potent as total bile both on 
secretin-stimulated (9) and on basal pancreatic 
secretion. CB exerted a significantly higher effect 
only on bicarbonate output after the highest dose 
given. It is noteworthy that the doses of TDC 
given alone corresponded to those applied with 
total bile. 
In contrast, Na-taurocholate (TC) was only a 
weak and dose-independent stimulus of secretin- 
induced hydrokinetic secretion without pro- 
voking a significant ecbolic effect in man (9). 
These results are consistent with those of Bjorns- 
son et al. (26)- who also found a significant 
increase of caerulein- and secretin-induced bicar- 
bonate secretion but not of trypsin secretion by 
intraduodenal perfusion of TC in man. On basal 
pancreatic secretion, however, TC did not exert a 
hydrokinetic effect. On the other hand, duodenal 
perfusion of TC provoked a marked hydrokinetic 
and a sparse ecbolic secretion under basal con- 
ditions in the anaesthetized cat (27). Species dif- 
ferences may account for this discrepancy. Other 
studies in man showed no influence or even an 
inhibiting effect of TC, when pancreatic secretion 
was stimulated by duodenal perfusion with essen- 
tial amino acids and monoolein, respectively 
(4, 6). In lower concentrations bile acids have 
also been reported to diminish, but in higher 
concentrations to enhance the stimulatory effect 
of fatty acids on pancreatic secretion (28). These 
discrepancies may partially be explained by 
species differences and differences in exper- 
imental design-bolus versus continuous per- 
fusion technique-or by the load of bile salts 
applied. Moreover, the interactions of digestive 
products and bile salts remain to be clarified by 
using a very potent bile salt like TDC. 
Osnes et al. (10,21) were the first to describe 
the release of plasma secretin with a subsequent 
increase of pancreatic secretion induced by intra- 
duodenal CB in man, but only doses of 6 g  CB 
were applied. The secretin reiease caused by bile, 
by TC, and by a mixture of bile salts has been 
confirmed by other studies (3,13,27). However, 
Burhol et a]. (11) were not able to demonstrate 
a significant increase of plasma secretin by bile. 
In our study the kinetics of plasma secretin con- 
centration was correlated to that of volume and 
bicarbonate secretion rate after each dose of CB 
and TDC. Moreover, integrated plasma secretin 
showed a dose-dependent increase after all doses 
of CB and TDC. Since the effect of CB and 
TDC is dose-dependent and the applied doses are 
within the physiologic range, a specific effect of 
these intraduodenal stimuli on secretin release 
has to be assumed. The pH of the instilled solu- 
tions cannot have influenced secretin levels, since 
secretin release in man occurs below a threshold 
of pH 3 (29). Furthermore, it is unlikely that the 
secretin increase observed is secondary to an acid 
release into the duodenum, since gastric juice was 
removed continuously by suction, and the pH of 
the duodenal aspirate was permanently within the 
neutral range. Thus, our data strongly support 
the hypothesis that secretin acts as a major 
mediator of pancreatic hydrokinetic secretion 
induced by intraduodenal CB and TDC in man. 
Cholinergic mechanisms and/or a release of 
cholecystokinin have been discussed as mediators 
of the ecbolic effect of bile and bile salts (30, 31). 
Forell (30) could show that propantheline, an 
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anticholinergic drug, caused a marked inhibition 
o f  the ecbolic effect of intraduodenal C B  but did 
not influence the hydrokinetic action. Davies et 
al. (31). however, found a postprandial decrease 
of plasma CCK concentrations and trypsin output 
after diversion o f  bile from the duodenum in dogs. 
Both pathways are also capable of eliciting PP 
from the pancreas (32,33). Therefore, plasma PP 
concentrations may serve as an indirect marker 
of  the involvement of cholinergic mechanisms 
and/or cholecystokinin release. Indeed, plasma 
PP concentrations rose significantly after each 
dose of CB and TDC,  and the kinetics was cor- 
related to that of trypsin secretion rate. More- 
over, the dose-dependent increase of integrated 
plasma PP after CB and T D C  intraduodenally 
supports the hypothesis that the observed aug- 
mentation of pancreatic enzyme output is a true 
ecbolic effect and not a 'washing out' phenom- 
enon (21). I t  is unlikely that the increase in PP 
observed is due to distension of the duodenum, 
since the instilled volumes were identical. It is 
also possible that the increase of PP is secondary 
to a release of other GI peptides like secretin, 
VIP, and GIP,  but so far this has been reported 
only for pharmacologic doses (34-36). The re- 
lease of PP by these peptides is noteworthy be- 
ciiuse not only an increase of secretin but also 
of VIP and G I P  has been observed after intra- 
duodenal CB (11, 37). PP for its part inhibits 
CCK-mediated gallbladder contraction and 
enzyme secretion of the pancreas in man (38). 
Therefore. the unequivocal PP release after the 
highest doses of CB and T D C  may explain the 
lack of  any further increase in trypsin secretion 
after these doses. 
C "  Jastrin as a hormonal mediator of intra- 
duodenal CB-. and TDC-induced increase of 
ccholic pancreatic secretion does not seem to 
play a n y  role in this effect. We observed only a 
marginal and no dose-dependent augmentation 
o f  plasma gastrin concentrations after both CB 
and TDC. Our results are in accordance with 
Londong et al. (39), who also found only a slight 
increase of gastrin after 6 g CB. Nor does plasma 
gastrin in physiologic concentrations stimulate 
exocrine pancreatic secretion (40.41). 
In conclusion, intraduodenal CB and TDC 
induce a dose-dependent increase of pancreatic 
hydrokinetic secretion which seems to be mainly 
mediated by secretin. Cholinergic reflexes and a 
CCK release must be considered as mediators of 
CB- and TDC-induced enzyme secretion and o f  
the concomitant PP release observed. On the 
other hand, gastrin seems to be of no importance. 
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